207 related articles for article (PubMed ID: 3490573)
21. [Circulating immune complexes and anti-IgG antibodies in rheumatoid arthritis].
Duquesnoy B; Santoro F; Wattre P; Delcambre B
Rev Rhum Mal Osteoartic; 1978 Jun; 45(6):417-21. PubMed ID: 308254
[TBL] [Abstract][Full Text] [Related]
22. [Is the demonstration of immune complex useful in the activity assessment of chronic polyarthritis?].
Schlumpf U; Ernst R; Christen P; von Felten A; Böni A
Schweiz Med Wochenschr; 1984 Jan; 114(4):118-30. PubMed ID: 6367028
[TBL] [Abstract][Full Text] [Related]
23. Comparison of immune complexes and complement components in arterial and venous blood of patients with rheumatoid arthritis.
Steven MM; Westedt ML; Daha MR; de Vries E; Cats A
J Rheumatol; 1986 Feb; 13(1):74-8. PubMed ID: 3701744
[TBL] [Abstract][Full Text] [Related]
24. Complement activating properties of complexes containing rheumatoid factor in synovial fluids and sera from patients with rheumatoid arthritis.
Elson CJ; Carter SD; Cottrell BJ; Scott DG; Bacon PA; Wallington TB
Clin Exp Immunol; 1985 Feb; 59(2):285-92. PubMed ID: 3978872
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of six tests for circulating IgG complexes with special reference to IgM rheumatoid factors: analysis of systemic lupus erythematosus and rheumatoid arthritis series.
Wager O; Lindström P; Räsänen JA; Kekomäki R; Ziola B; Salmi A; Isomäki H; Skrifvars B; Penttinen K
Clin Exp Immunol; 1981 Oct; 46(1):149-60. PubMed ID: 7337967
[TBL] [Abstract][Full Text] [Related]
26. Relationship between the articular manifestations of rheumatoid arthritis and circulating immune complexes detected by three methods and specific classes of rheumatoid factors.
Lessard J; Nunnery E; Cecere F; McDuffy S; Pope RM
J Rheumatol; 1983 Jun; 10(3):411-7. PubMed ID: 6604160
[TBL] [Abstract][Full Text] [Related]
27. Circulating immune complex levels measured by new ELISA kits utilizing monoclonal anti-C1q and anti-C3d antibodies correlate with clinical activities of SLE but not with those of RA.
Yoshinoya S; Mizoguchi Y; Aotsuka S; Yokohari R; Nishioka K; Miyamoto T
J Clin Lab Immunol; 1992; 38(4):161-73. PubMed ID: 11270517
[TBL] [Abstract][Full Text] [Related]
28. Immune complexes in early arthritis. L Detection of immune complexes before rheumatoid arthritis is definite.
Jones VE; Jacoby RK; Wallington T; Holt P
Clin Exp Immunol; 1981 Jun; 44(3):512-21. PubMed ID: 6976861
[TBL] [Abstract][Full Text] [Related]
29. IgG rheumatoid factor, complement and immune complexes in rheumatoid synovitis and vasculitis: comparative and serial studies during cytotoxic therapy.
Scott DG; Bacon PA; Allen C; Elson CJ; Wallington T
Clin Exp Immunol; 1981 Jan; 43(1):54-63. PubMed ID: 7249394
[TBL] [Abstract][Full Text] [Related]
30. Elevated serum immune complex levels in Pogosta disease, an acute alphavirus infection with rash and arthritis.
Julkunen I; Brummer-Korvenkontio M; Hautanen A; Kuusisto P; Lindström P; Wager O; Penttinen K
J Clin Lab Immunol; 1986 Oct; 21(2):77-82. PubMed ID: 3029375
[TBL] [Abstract][Full Text] [Related]
31. Studies of circulating immune complexes in ankylosing spondylitis.
Kinsella TD; Lanteigne C; Lewkonia RM; Fritzler MJ
Clin Invest Med; 1982; 5(4):223-30. PubMed ID: 7160109
[TBL] [Abstract][Full Text] [Related]
32. The effect of antirheumatic drugs on circulating immune complexes in rheumatoid arthritis.
Forster PJ; McConkey B
Q J Med; 1986 Jan; 58(225):29-42. PubMed ID: 2871585
[TBL] [Abstract][Full Text] [Related]
33. Circulating immune complexes in patients with cryptogenic fibrosing alveolitis.
Haslam PL; Thompson B; Mohammed I; Townsend PJ; Hodson ME; Holborow EJ; Turner-Warwick M
Clin Exp Immunol; 1979 Sep; 37(3):381-90. PubMed ID: 315841
[TBL] [Abstract][Full Text] [Related]
34. Complement-mediated solubilization of immune complexes in systemic lupus erythematosus.
Sakurai T; Fujita T; Kono I; Kabashima T; Yamane K; Tamura N; Kashiwagi H
Clin Exp Immunol; 1982 Apr; 48(1):37-42. PubMed ID: 6979449
[TBL] [Abstract][Full Text] [Related]
35. Detection and partial characterization of immune complexes in patients with rheumatoid arthritis plus Sjogren's syndrome and with Sjogren's syndrome alone.
Yoshinoya S; McDuffy S; Alarcon-Segovia D; Pope RM
Clin Exp Immunol; 1982 May; 48(2):339-47. PubMed ID: 6980743
[TBL] [Abstract][Full Text] [Related]
36. Binding of complement component C5 to model immune complexes and the use of anti-C5 antibodies for determination of C5-containing circulating immune complexes.
Larsson A; Sjöquist J
J Clin Lab Immunol; 1989 Jan; 28(1):5-9. PubMed ID: 2724329
[TBL] [Abstract][Full Text] [Related]
37. Heterogeneity of IgM/IgG cryocomplexes: immunological-clinical correlation.
MacKechnie HL; Ogryzlo MA; Pruzanski W
J Rheumatol; 1975 Jun; 2(2):225-40. PubMed ID: 807730
[TBL] [Abstract][Full Text] [Related]
38. [Beta2 microglobulin, antibeta2 microglobulin activity and circulating immune complexes in rheumatoid arthritis. Serum and synovial study].
Duquesnoy B; Asfour M; Santoro F; Vandemeulebroucke B; Hochart JP; Delcambre B
Rev Rhum Mal Osteoartic; 1980; 47(7-9):481-7. PubMed ID: 6158754
[TBL] [Abstract][Full Text] [Related]
39. Interference of rheumatoid factor activity by aspartame, a dipeptide methyl ester.
Ramsland PA; Movafagh BF; Reichlin M; Edmundson AB
J Mol Recognit; 1999; 12(4):249-57. PubMed ID: 10440996
[TBL] [Abstract][Full Text] [Related]
40. Activation of the immune system and inflammatory activity in relation to markers of atherothrombotic disease and atherosclerosis in rheumatoid arthritis.
Wållberg-Jonsson S; Cvetkovic JT; Sundqvist KG; Lefvert AK; Rantapää-Dahlqvist S
J Rheumatol; 2002 May; 29(5):875-82. PubMed ID: 12022343
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
